GeneDx Holdings
265 hedge funds and large institutions have $3.24B invested in GeneDx Holdings in 2025 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 85 increasing their positions, 82 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
5.6% less ownership
Funds ownership: 110.39% → 104.78% (-5.6%)
26% less call options, than puts
Call options by funds: $122M | Put options by funds: $164M
Holders
265
Holding in Top 10
11
Calls
$122M
Puts
$164M
Top Buyers
| 1 | +$48.2M | |
| 2 | +$37.1M | |
| 3 | +$36.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$31.5M |
Top Sellers
| 1 | -$91.8M | |
| 2 | -$85.7M | |
| 3 | -$53.9M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$49.9M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$44.3M |
